Elevated serum levels of IL-2R, IL-1RA, and CXCL9 are associated with a poor prognosis in follicular lymphoma
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Elevated serum levels of IL-2R, IL-1RA, and CXCL9 are associated with a poor prognosis in follicular lymphoma
Authors
Keywords
-
Journal
BLOOD
Volume 125, Issue 6, Pages 992-998
Publisher
American Society of Hematology
Online
2014-11-25
DOI
10.1182/blood-2014-06-583369
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cytokines in serum in relation to future non-Hodgkin lymphoma risk: Evidence for associations by histologic subtype
- (2014) Kerstin L. Edlefsen et al. INTERNATIONAL JOURNAL OF CANCER
- IP-10/CXCL10 and MIG/CXCL9 as novel markers for the diagnosis of lymphoma-associated hemophagocytic syndrome
- (2013) Hayato Maruoka et al. ANNALS OF HEMATOLOGY
- A prospective study of 67 serum immune and inflammation markers and risk of non-Hodgkin lymphoma
- (2013) M. P. Purdue et al. BLOOD
- High PD-1 expression and suppressed cytokine signaling distinguish T cells infiltrating follicular lymphoma tumors from peripheral T cells
- (2013) J. H. Myklebust et al. BLOOD
- Improvements in observed and relative survival in follicular grade 1-2 lymphoma during 4 decades: the Stanford University experience
- (2013) D. Tan et al. BLOOD
- Non-Hodgkin Lymphoma and Circulating Markers of Inflammation and Adiposity in a Nested Case-Control Study: The Multiethnic Cohort
- (2013) S. M. Conroy et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Elevated soluble IL-2 receptor levels correlate with tumor bulk of follicular lymphomas with intestinal involvement
- (2013) Masaya Iwamuro et al. CLINICAL BIOCHEMISTRY
- Prognostic Significance of Pretreatment Serum Cytokines in Classical Hodgkin Lymphoma
- (2013) P. R. Marri et al. CLINICAL CANCER RESEARCH
- Clinical Significance of Serum-Soluble Interleukin-2 Receptor in Patients With Follicular Lymphoma
- (2013) Tetsuichi Yoshizato et al. Clinical Lymphoma Myeloma & Leukemia
- Rates and Outcomes of Follicular Lymphoma Transformation in the Immunochemotherapy Era: A Report From the University of Iowa/Mayo Clinic Specialized Program of Research Excellence Molecular Epidemiology Resource
- (2013) Brian K. Link et al. JOURNAL OF CLINICAL ONCOLOGY
- Soluble IL-2 receptor and beta-2 microglobulin as possible serologic markers of neurologic disease in HTLV-1 infection
- (2013) Cristina Toledo-Cornell et al. JOURNAL OF MEDICAL VIROLOGY
- Elevated pretreatment serum levels of interferon-inducible protein-10 (CXCL10) predict disease relapse and prognosis in diffuse large B-cell lymphoma patients
- (2012) Stephen M. Ansell et al. AMERICAN JOURNAL OF HEMATOLOGY
- A Phase I Dose-Finding Trial of Recombinant Interleukin-21 and Rituximab in Relapsed and Refractory Low Grade B-cell Lymphoproliferative Disorders
- (2012) J. M. Timmerman et al. CLINICAL CANCER RESEARCH
- Pretreatment circulating serum cytokines associated with follicular and diffuse large B-cell lymphoma: A clinic-based case-control study
- (2012) Bridget Charbonneau et al. CYTOKINE
- IL-12 upregulates TIM-3 expression and induces T cell exhaustion in patients with follicular B cell non-Hodgkin lymphoma
- (2012) Zhi-Zhang Yang et al. JOURNAL OF CLINICAL INVESTIGATION
- Phase III Randomized Intergroup Trial of CHOP Plus Rituximab Compared With CHOP Chemotherapy Plus131Iodine-Tositumomab for Previously Untreated Follicular Non-Hodgkin Lymphoma: SWOG S0016
- (2012) Oliver W. Press et al. JOURNAL OF CLINICAL ONCOLOGY
- Abundant expression of interleukin-21 receptor in follicular lymphoma cells is associated with more aggressive disease
- (2012) Brianne Wood et al. LEUKEMIA & LYMPHOMA
- MYD88 L265P Somatic Mutation in Waldenström's Macroglobulinemia
- (2012) Steven P. Treon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Stromal Cell Contribution to Human Follicular Lymphoma Pathogenesis
- (2012) Frédéric Mourcin et al. Frontiers in Immunology
- Soluble IL-2R facilitates IL-2-mediated immune responses and predicts reduced survival in follicular B-cell non-Hodgkin lymphoma
- (2011) Z.-Z. Yang et al. BLOOD
- Plasma Cytokines and Future Risk of Non-Hodgkin Lymphoma (NHL): A Case-Control Study Nested in the Italian European Prospective Investigation into Cancer and Nutrition
- (2010) F. Saberi Hosnijeh et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Chemokines in cancer related inflammation
- (2010) Paola Allavena et al. EXPERIMENTAL CELL RESEARCH
- Heterogeneous expression and function of IL-21R and susceptibility to IL-21−mediated apoptosis in follicular lymphoma cells
- (2010) Daniela de Totero et al. EXPERIMENTAL HEMATOLOGY
- Perivascular expression of CXCL9 and CXCL12 in primary central nervous system lymphoma: T-cell infiltration and positioning of malignant B cells
- (2010) Daniel Venetz et al. INTERNATIONAL JOURNAL OF CANCER
- Follicular lymphoma cell niche: identification of a preeminent IL-4-dependent TFH–B cell axis
- (2010) C Pangault et al. LEUKEMIA
- Oncogenically active MYD88 mutations in human lymphoma
- (2010) Vu N. Ngo et al. NATURE
- Serum cytokines in follicular lymphoma. Correlation of TGF-β and VEGF with survival
- (2009) Sana Intidhar Labidi et al. ANNALS OF HEMATOLOGY
- Chemokines and cancer: migration, intracellular signalling and intercellular communication in the microenvironment
- (2008) Morgan O'Hayre et al. BIOCHEMICAL JOURNAL
- IL-4 protein expression and basal activation of Erk in vivo in follicular lymphoma
- (2008) K. R. Calvo et al. BLOOD
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started